​

Artelo Biosciences (ARTL) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

ARTL Stock Rating

Artelo Biosciences stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

ARTL Price Target Upside V Benchmarks

TypeNameUpside
StockArtelo Biosciences-
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.18$1.18$1.18
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2511---2
May, 2521---3
Apr, 2521---3
Mar, 2521---3
Feb, 2521---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 01, 2024EF HuttonBuyinitialise
Nov 01, 2021H.C. WainwrightBuyinitialise

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.49------
Avg Forecast$-3.04$-2.56$-1.78$-0.80$-0.57$-0.46$0.35
High Forecast$-3.04$-2.24$-1.21$-0.40$-0.37$-0.25$0.35
Low Forecast$-3.04$-2.86$-2.34$-1.21$-0.84$-0.73$0.35
Surprise %14.80%------

Revenue Forecast

$49M $49M $49M $50M $50M $50M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-------
Avg Forecast-----$49.29M$49.78M
High Forecast-----$49.29M$49.78M
Low Forecast-----$49.29M$49.78M
Surprise %-------

Net Income Forecast

$-10M $-7M $-4M $-1M $2M $5M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-9.87M------
Avg Forecast$-8.62M$-7.23M$-5.04M$-2.27M$-1.70M$-1.39M$991.55K
High Forecast$-8.62M$-6.35M$-3.44M$-1.13M$-1.04M$-703.18K$991.55K
Low Forecast$-8.62M$-8.11M$-6.63M$-3.42M$-2.37M$-2.08M$991.55K
Surprise %14.52%------

ARTL Forecast FAQ

Is Artelo Biosciences stock a buy?

Artelo Biosciences stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Artelo Biosciences is a favorable investment for most analysts.

What is Artelo Biosciences's price target?

Artelo Biosciences's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $1.18.

How does Artelo Biosciences stock forecast compare to its benchmarks?

Artelo Biosciences's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for Artelo Biosciences over the past three months?

  • June 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 66.67% Strong Buy, 33.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 66.67% Strong Buy, 33.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Artelo Biosciences’s EPS forecast?

Artelo Biosciences's average annual EPS forecast for its fiscal year ending in December 2023 is $-2.56, marking a -26.65% decrease from the reported $-3.49 in 2022. Estimates for the following years are $-1.78 in 2024, $-0.8 in 2025, $-0.57 in 2026, $-0.46 in 2027, and $0.35 in 2028.

What is Artelo Biosciences’s revenue forecast?

Artelo Biosciences's average annual revenue forecast for its fiscal year ending in December 2023 is $0, reflecting a 0% decrease from the reported $0 in 2022. The forecast for 2024 is $0, followed by $0 for 2025, $0 for 2026, $49.29M for 2027, and $49.78M for 2028.

What is Artelo Biosciences’s net income forecast?

Artelo Biosciences's net income forecast for the fiscal year ending in December 2023 stands at $-7.228M, representing a -26.80% decrease from the reported $-9.874M in 2022. Projections indicate $-5.036M in 2024, $-2.273M in 2025, $-1.704M in 2026, $-1.392M in 2027, and $991.55K in 2028.